Pfizer’s mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported. The results, published Nov. 19 in The New England Journal of Medicine, suggest that mRNA technology may help improve protection in future flu seasons. The Pfizer flu vaccine uses the same type of messenger RNA science… read on > read on >











-300x200.jpeg)







